Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani BN, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS. Ringdén O, et al. Among authors: khera n. Biol Blood Marrow Transplant. 2014 Nov;20(11):1777-84. doi: 10.1016/j.bbmt.2014.07.009. Epub 2014 Jul 17. Biol Blood Marrow Transplant. 2014. PMID: 25042734 Free PMC article.
Multiple Myeloma: Current Clinical Landscape and Compounding Costs.
Beck K, Sandahl T, Ailawadhi S, Khera N, Jensen C. Beck K, et al. Among authors: khera n. Curr Hematol Malig Rep. 2023 Oct;18(5):201-215. doi: 10.1007/s11899-023-00705-8. Epub 2023 Jul 21. Curr Hematol Malig Rep. 2023. PMID: 37477783 Review.
Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.
Khera N, Jinneman J, Storer BE, Heimfeld S, O'Meara MM, Chauncey TR, Lee SJ, Linenberger M. Khera N, et al. Biol Blood Marrow Transplant. 2012 Feb;18(2):220-8. doi: 10.1016/j.bbmt.2011.06.003. Epub 2011 Jun 15. Biol Blood Marrow Transplant. 2012. PMID: 21703976 Free PMC article.
Validation of measurement scales in ocular graft-versus-host disease.
Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM, Carpenter PA, Heffernan MJ, Jacobsohn D, Jagasia MH, Pidala J, Khera N, Vogelsang GB, Weisdorf D, Martin PJ, Pavletic SZ, Lee SJ; Chronic GVHD Consortium. Inamoto Y, et al. Among authors: khera n. Ophthalmology. 2012 Mar;119(3):487-93. doi: 10.1016/j.ophtha.2011.08.040. Epub 2011 Dec 6. Ophthalmology. 2012. PMID: 22153706 Free PMC article.
HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.
Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani BN, Aljurf MD, Cairo MS, Drobyski WR, George B, Hahn T, Khera N, Litzow MR, Loren AW, Saber W, Arora M, Urbano-Ispizua A, Cutler C, Flowers ME, Spellman SR. Battiwalla M, et al. Among authors: khera n. Biol Blood Marrow Transplant. 2012 Aug;18(8):1302-8. doi: 10.1016/j.bbmt.2012.02.011. Epub 2012 Mar 10. Biol Blood Marrow Transplant. 2012. PMID: 22414493 Free PMC article.
Clinical benefit of response in chronic graft-versus-host disease.
Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J, Cutler C, Pavletic SZ, Arora M, Jacobsohn D, Carpenter PA, Flowers ME, Khera N, Vogelsang GB, Weisdorf D, Storer BE, Lee SJ; Chronic GVHD Consortium. Inamoto Y, et al. Among authors: khera n. Biol Blood Marrow Transplant. 2012 Oct;18(10):1517-24. doi: 10.1016/j.bbmt.2012.05.016. Epub 2012 Jun 6. Biol Blood Marrow Transplant. 2012. PMID: 22683612 Free PMC article.
191 results